QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hawkeye who wrote (778)	11/30/1999 11:52:00 AM
From: tnsaf	Read Replies (1) of 1321

I would say QLTI's rise is due to the expectations of Visudyne, not its cancer therapies. Perhaps the article ignored the AMD aspect to improve his comparison with Biomera's cancer treatments. And BIOM has competition in cancer vaccines. Jason

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next